$EYEN
Eyenovia Inc

2019 Q2 Form 10-Q Financial Statement

#000114420419026008 Filed on May 14, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2019 Q1 2018 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.810M $1.940M $2.060M
YoY Change 98.9% 44.78% 338.3%
% of Gross Profit
Research & Development $3.570M $4.009M $4.130M
YoY Change 48.0% 91.44% 144.38%
% of Gross Profit
Depreciation & Amortization $10.00K $2.553K $0.00
YoY Change -52.06% -100.0%
% of Gross Profit
Operating Expenses $5.380M $5.952M $6.180M
YoY Change 62.0% 73.43% 186.11%
Operating Profit -$5.952M
YoY Change 73.43%
Interest Expense $40.00K $19.28K $0.00
YoY Change 801.97%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$5.330M -$5.930M -$6.180M
YoY Change 60.54% 72.89% 186.11%
Income Tax
% Of Pretax Income
Net Earnings -$5.330M -$5.932M -$6.180M
YoY Change 60.59% 72.98% 186.11%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$443.1K -$497.5K -$602.9K
COMMON SHARES
Basic Shares Outstanding 12.02M 12.02M 10.09M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.240M $14.32M $19.73M
YoY Change -62.38% -48.12% 275.81%
Cash & Equivalents $14.32M $19.73M
Short-Term Investments
Other Short-Term Assets $470.0K $490.0K $130.0K
YoY Change 95.83% 36.11% 225.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $9.810M $14.88M $19.86M
YoY Change -60.45% -46.8% 275.68%
LONG-TERM ASSETS
Property, Plant & Equipment $30.00K $34.19K $36.74K
YoY Change 82.07% 51.03% 31.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.0K $120.0K $120.0K
YoY Change -63.64%
Total Long-Term Assets $230.0K $152.0K $154.5K
YoY Change 1295.89% 571.46% -56.67%
TOTAL ASSETS
Total Short-Term Assets $9.810M $14.88M $19.86M
Total Long-Term Assets $230.0K $152.0K $154.5K
Total Assets $10.04M $15.03M $20.02M
YoY Change -59.55% -46.3% 254.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.800M $2.061M $1.510M
YoY Change 148.96% 275.32% 512.67%
Accrued Expenses $540.0K $450.0K $1.570M
YoY Change 10.2% -16.67% 423.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.370M $2.525M $3.099M
YoY Change 85.19% 124.76% 460.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $40.00K $40.00K $40.00K
YoY Change
Total Long-Term Liabilities $40.00K $40.00K $40.00K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.370M $2.525M $3.099M
Total Long-Term Liabilities $40.00K $40.00K $40.00K
Total Liabilities $2.420M $2.568M $3.140M
YoY Change 89.06% 129.3% 468.25%
SHAREHOLDERS EQUITY
Retained Earnings -$42.45M -$36.51M
YoY Change 87.07% 89.57%
Common Stock $1.202K $1.147K
YoY Change 20.93% 346.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.620M $12.46M $16.88M
YoY Change
Total Liabilities & Shareholders Equity $10.04M $15.03M $20.02M
YoY Change -59.55% -46.3% 254.68%

Cashflow Statement

Concept 2019 Q2 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income -$5.330M -$5.932M -$6.180M
YoY Change 60.59% 72.98% 186.11%
Depreciation, Depletion And Amortization $10.00K $2.553K $0.00
YoY Change -52.06% -100.0%
Cash From Operating Activities -$5.140M -$5.897M -$4.100M
YoY Change 69.08% 146.63% 106.03%
INVESTING ACTIVITIES
Capital Expenditures -$30.00K
YoY Change 200.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$30.00K
YoY Change 200.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 70.00K 483.9K 2.820M
YoY Change -98.04% -1862.5%
NET CHANGE
Cash From Operating Activities -5.140M -5.897M -4.100M
Cash From Investing Activities -30.00K
Cash From Financing Activities 70.00K 483.9K 2.820M
Net Change In Cash -5.070M -5.413M -1.310M
YoY Change 66.78% -124.22% -39.35%
FREE CASH FLOW
Cash From Operating Activities -$5.140M -$5.897M -$4.100M
Capital Expenditures -$30.00K
Free Cash Flow -$4.070M
YoY Change 105.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14315348
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19728200
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
560329
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
132756
CY2019Q1 us-gaap Assets Current
AssetsCurrent
14875677
CY2018Q4 us-gaap Assets Current
AssetsCurrent
19860956
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34185
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36738
CY2019Q1 us-gaap Assets
Assets
15027662
CY2018Q4 us-gaap Assets
Assets
20015494
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2061043
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1509524
CY2019Q1 eyen Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
46825
CY2018Q4 eyen Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
677213
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2524929
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3098841
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
1202
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
1147
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
54905009
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
53388216
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42446678
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36514294
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
12459533
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
16875069
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15027662
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20015494
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1618346
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1746291
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6000000
CY2019Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
14065348
CY2018Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
19478200
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4008896
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2094095
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1942763
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1337649
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
5951659
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
3431744
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5951659
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3431744
CY2019Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
19275
CY2018Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2137
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-5932384
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-3429607
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.50
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11919973
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7561915
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 us-gaap Prepaid Insurance
PrepaidInsurance
395629
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
39465
CY2019Q1 eyen Prepaid Patent Expense
PrepaidPatentExpense
19535
CY2018Q4 eyen Prepaid Patent Expense
PrepaidPatentExpense
10562
CY2019Q1 eyen Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
14153
CY2018Q4 eyen Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
0
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
560329
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
132756
CY2019Q1 eyen Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
27659
CY2018Q4 eyen Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
375204
CY2019Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4801
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
111728
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
427573
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
320989
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
551519
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
302754
CY2019Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-630388
CY2018Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
400996
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5896740
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2390945
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
483888
CY2019Q1 eyen Accrued Legal Expenses Current
AccruedLegalExpensesCurrent
0
CY2018Q4 eyen Accrued Legal Expenses Current
AccruedLegalExpensesCurrent
168650
CY2019Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8506
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12165
CY2019Q1 eyen Accrued Expenses And Other Liabilities Currents
AccruedExpensesAndOtherLiabilitiesCurrents
46825
CY2018Q4 eyen Accrued Expenses And Other Liabilities Currents
AccruedExpensesAndOtherLiabilitiesCurrents
677213
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-5932384
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-3429607
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2553
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5325
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1032960
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
650576
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24743503
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5412852
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
22352558
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19728200
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5249511
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14315348
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27602069
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25089000
CY2019Q1 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
0
CY2018Q1 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
345497
CY2019Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0
CY2018Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
464
CY2019Q1 eyen Payment Of Accrued Issuance Costs
PaymentOfAccruedIssuanceCosts
0
CY2018Q1 eyen Payment Of Accrued Issuance Costs
PaymentOfAccruedIssuanceCosts
-133000
CY2018Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
9000
CY2015Q4 eyen Minority Interest Ownership Percentage In Company
MinorityInterestOwnershipPercentageInCompany
0.05
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0253
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.39
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
0
CY2019Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2725451
CY2019Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
CY2019Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
236466
CY2019Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1598181
CY2019Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
shares vest over three years from the date of grant with one-third vesting on the one-year anniversary of the date of grant and the balance vesting monthly over the remaining 24 months, subject to continued service to the Company.
CY2019Q1 us-gaap Security Deposit
SecurityDeposit
117800
CY2018Q4 us-gaap Security Deposit
SecurityDeposit
117800
CY2019Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
43200
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
41584
CY2019Q1 us-gaap Liabilities
Liabilities
2568129
CY2018Q4 us-gaap Liabilities
Liabilities
3140425
CY2019Q1 eyen Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
1616
CY2018Q1 eyen Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
0
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
483888
CY2018Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2019Q1 us-gaap Stock Issued1
StockIssued1
24
CY2018Q1 us-gaap Stock Issued1
StockIssued1
0
CY2019Q1 eyen Reduction In Additional Paid In Capitalstock Issuance Costs
ReductionInAdditionalPaidInCapitalstockIssuanceCosts
0
CY2018Q1 eyen Reduction In Additional Paid In Capitalstock Issuance Costs
ReductionInAdditionalPaidInCapitalstockIssuanceCosts
-195700
CY2016Q3 us-gaap Payments For Rent
PaymentsForRent
3000
CY2018Q1 us-gaap Payments For Rent
PaymentsForRent
4000
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M6D
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y
CY2019Q1 eyen Percentage Reduction In Preservative
PercentageReductionInPreservative
0.75
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1032960
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
16875069
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
483888
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1032960
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-5932384
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
12459533
CY2019Q1 eyen Proceeds Of Stock Issued During Period Gross
ProceedsOfStockIssuedDuringPeriodGross
27300000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2752197
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
5090673
CY2018Q1 eyen Stock Issued During Period Value Conversion Of Convertible Securities Upon Initial Public Offering
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesUponInitialPublicOffering
0
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
650576
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-3429607
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
26859445
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.74
CY2019Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
846979
CY2019Q1 eyen Prepaid Rent And Security Deposit
PrepaidRentAndSecurityDeposit
35331
CY2018Q4 eyen Prepaid Rent And Security Deposit
PrepaidRentAndSecurityDeposit
75729
CY2019Q1 eyen Credit Card Payable
CreditCardPayable
5859
CY2018Q4 eyen Credit Card Payable
CreditCardPayable
9466
CY2019Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
417061
CY2018Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
912104
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-495043
CY2019Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2211000
CY2019Q1 eyen Stock Issued During Period Value Stock Options Exercised On Cashless Basis
StockIssuedDuringPeriodValueStockOptionsExercisedOnCashlessBasis
0
CY2018Q1 eyen Stock Issued During Period Value New Issues One
StockIssuedDuringPeriodValueNewIssuesOne
24547803
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
609322
CY2019Q1 us-gaap Severance Costs1
SeveranceCosts1
419000
CY2019Q1 us-gaap Supplemental Unemployment Benefits Salary Continuation
SupplementalUnemploymentBenefitsSalaryContinuation
1677000
CY2019Q1 eyen Payroll Taxes Receivable
PayrollTaxesReceivable
68681
CY2018Q4 eyen Payroll Taxes Receivable
PayrollTaxesReceivable
0
CY2019Q1 eyen Prepaid Conference Expenses
PrepaidConferenceExpenses
27000
CY2018Q4 eyen Prepaid Conference Expenses
PrepaidConferenceExpenses
7000
CY2019Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
252404
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
217614
CY2019Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
164657
CY2018Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
694490
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
417061
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
912104
CY2019Q1 dei Document Type
DocumentType
10-Q
CY2019Q1 dei Amendment Flag
AmendmentFlag
false
CY2019Q1 dei Document Period End Date
DocumentPeriodEndDate
2019-03-31
CY2019Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019Q1 dei Entity Registrant Name
EntityRegistrantName
EYENOVIA, INC.
CY2019Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001682639
CY2019Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019Q1 dei Trading Symbol
TradingSymbol
EYEN
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12019148
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2019Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12019148
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11468996
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12019148
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11468996
CY2018Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
483888
CY2019Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
320001
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.24
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Vesting Number
SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
124210
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
650576

Files In Submission

Name View Source Status
0001144204-19-026008-index-headers.html Edgar Link pending
0001144204-19-026008-index.html Edgar Link pending
0001144204-19-026008.txt Edgar Link pending
0001144204-19-026008-xbrl.zip Edgar Link pending
eyen-20190331.xml Edgar Link completed
eyen-20190331.xsd Edgar Link pending
eyen-20190331_cal.xml Edgar Link unprocessable
eyen-20190331_def.xml Edgar Link unprocessable
eyen-20190331_lab.xml Edgar Link unprocessable
eyen-20190331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv520406_10q.htm Edgar Link pending
tv520406_ex31-1.htm Edgar Link pending
tv520406_ex31-2.htm Edgar Link pending
tv520406_ex32-1.htm Edgar Link pending
tv520406_ex32-2.htm Edgar Link pending